Marshall Wace’s Cingulate CING Stock Holding History

Marshall Wace’s Portfolio CING Stock Details CING Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-92,934	Closed	-$577K	–	3226
2026 Q1	$577K	Buy	+92,934	New	+$593K	﹤0.01%	2382

Other funds holding CING

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

BCV Asset Management Winnipeg $3.31B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace's CING Position: Q2 2026 in Review

Marshall Wace sold out of Cingulate (CING) in Q2 2026, closing a stake of 92,934 shares — an estimated $577K sold.

Marshall Wace first reported a position in CING in Q1 2026 and held it in 1 quarter. The position peaked at $577K in Q1 2026. 33 funds tracked by Wall St. Rank hold CING as of Q2 2026.

Marshall Wace reported no remaining Cingulate position as of Q2 2026 after selling out during the quarter.
Marshall Wace sold 92,934 Cingulate shares in Q2 2026, an estimated $577K.
Marshall Wace first reported a position in Cingulate in Q1 2026 and held it in 1 quarter.
Marshall Wace's Cingulate position peaked at $577K in Q1 2026.
33 funds tracked by Wall St. Rank held Cingulate as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.